{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:25:55Z","timestamp":1790663155628,"version":"4.1.0"},"reference-count":97,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Coevolution occurs between viruses and their hosts. The hosts need to evolve means to eliminate pathogenic virus infections, and the viruses, for their own survival and multiplication, have to develop mechanisms to escape clearance by hosts. Hepatitis C virus (HCV) of\n                      <jats:italic toggle=\"yes\">Flaviviridae<\/jats:italic>\n                      is a pathogen which infects human liver and causes hepatitis, a condition of liver inflammation. Unlike most of the other flaviviruses, HCV has an excellent ability to evade host immunity to establish chronic infection. The persistent liver infection leads to chronic hepatitis, liver cirrhosis, hepatocellular carcinoma (HCC), as well as extrahepatic HCV-related diseases. HCV genomic RNA only expresses 10 proteins, many of which bear functions, in addition to those involved in HCV life cycle, for assisting the virus to develop its persistency. HCV core protein is a structural protein which encapsulates HCV genomic RNA and assembles into nucleocapsids. The core protein is also found to exert functions to affect host inflammation and immune responses by altering a variety of host pathways. This paper reviews the studies regarding the HCV core protein-induced alterations of host immunity and inflammatory responses, as well as the involvements of the HCV core protein in pro- and anti-inflammatory cytokine stimulations, host cellular transcription, lipid metabolism, cell apoptosis, cell proliferations, immune cell differentiations, oxidative stress, and hepatocyte steatosis, which leads to liver fibrosis, cirrhosis, and HCC. Implications of roles played by the HCV core protein in therapeutic resistance are also discussed.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/tcmj.tcmj_97_21","type":"journal-article","created":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T15:45:45Z","timestamp":1632498345000},"page":"139-147","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Hepatitis C virus core protein"],"prefix":"10.4103","volume":"34","author":[{"given":"Hemalatha","family":"Mani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jui-Hung","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Jen","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Chun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Je-Wen","family":"Liou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-5-20240828","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.4049\/jimmunol.170.11.5615","article-title":"Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation","volume":"170","author":"Dolganiuc","year":"2003","journal-title":"J Immunol"},{"key":"R3-5-20240828","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.clim.2009.10.007","article-title":"HCV-related hepatocellular carcinoma: From chronic inflammation to cancer","volume":"134","author":"Castello","year":"2010","journal-title":"Clin Immunol"},{"key":"R4-5-20240828","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/jgh.12023","article-title":"Hepatic stellate cells, liver innate immunity, and hepatitis C virus","volume":"28","author":"Wang","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"R5-5-20240828","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.3390\/ijms21093057","article-title":"Hepatitis C virus and hepatocellular carcinoma: When the host loses its grip","volume":"21","author":"Goto","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R6-5-20240828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1089-3261(02)00066-1","article-title":"Structural biology of hepatitis C virus","volume":"7","author":"Penin","year":"2003","journal-title":"Clin Liver Dis"},{"key":"R7-5-20240828","first-page":"117","article-title":"Hepatitis C virus core protein: Possible roles in viral pathogenesis","volume":"242","author":"Lai","year":"2000","journal-title":"Curr Top Microbiol Immunol"},{"key":"R8-5-20240828","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1365-2893.2000.00201.x","article-title":"Properties of the hepatitis C virus core protein: A structural protein that modulates cellular processes","volume":"7","author":"McLauchlan","year":"2000","journal-title":"J Viral Hepat"},{"key":"R9-5-20240828","first-page":"7559","article-title":"Induction of Huh-7 cell apoptosis by HCV core proteins via CK1\u03b1-p53-Bid signaling pathway","volume":"17","author":"Shen","year":"2018","journal-title":"Mol Med Rep"},{"key":"R10-5-20240828","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s11262-015-1253-2","article-title":"Regulation of HepG2 cell apoptosis by hepatitis C virus (HCV) core protein via the sirt1-p53-bax pathway","volume":"51","author":"Feng","year":"2015","journal-title":"Virus Genes"},{"key":"R11-5-20240828","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/viro.2000.0541","article-title":"The HCV core protein acts as a positive regulator of fas-mediated apoptosis in a human lymphoblastoid T cell line","volume":"276","author":"Hahn","year":"2000","journal-title":"Virology"},{"key":"R12-5-20240828","first-page":"217","article-title":"Chronic inflammation and cancer","volume":"16","author":"Shacter","year":"2002","journal-title":"Oncology (Williston Park"},{"key":"R13-5-20240828","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1086\/429492","article-title":"Cellular immune responses against hepatitis C virus","volume":"41","author":"Koziel","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R14-5-20240828","first-page":"344","article-title":"Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology","volume":"3","author":"Weiskirchen","year":"2014","journal-title":"Hepatobiliary Surg Nutr"},{"key":"R15-5-20240828","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1126\/science.282.5386.103","article-title":"Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy","volume":"282","author":"Neumann","year":"1998","journal-title":"Science"},{"key":"R16-5-20240828","doi-asserted-by":"crossref","first-page":"528","DOI":"10.4254\/wjh.v5.i10.528","article-title":"Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations","volume":"5","author":"Zampino","year":"2013","journal-title":"World J Hepatol"},{"key":"R17-5-20240828","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nature04077","article-title":"Unravelling hepatitis C virus replication from genome to function","volume":"436","author":"Lindenbach","year":"2005","journal-title":"Nature"},{"key":"R18-5-20240828","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2183\/pjab.85.217","article-title":"Hepatitis C virus utilizes lipid droplet for production of infectious virus","volume":"85","author":"Ogawa","year":"2009","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"R19-5-20240828","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/j.1462-5822.2006.00848.x","article-title":"Core protein domains involved in hepatitis C virus-like particle assembly and budding at the endoplasmic reticulum membrane","volume":"9","author":"Hourioux","year":"2007","journal-title":"Cell Microbiol"},{"key":"R20-5-20240828","doi-asserted-by":"crossref","first-page":"37481","DOI":"10.1074\/jbc.M506412200","article-title":"Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production","volume":"280","author":"Korenaga","year":"2005","journal-title":"J Biol Chem"},{"key":"R21-5-20240828","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1128\/JVI.79.2.1271-1281.2005","article-title":"Molecular determinants for subcellular localization of hepatitis C virus core protein","volume":"79","author":"Suzuki","year":"2005","journal-title":"J Virol"},{"key":"R22-5-20240828","doi-asserted-by":"crossref","first-page":"10847","DOI":"10.1074\/jbc.M110.217653","article-title":"Extracellular hepatitis C virus core protein activates STAT3 in human monocytes\/macrophages\/dendritic cells via an IL-6 autocrine pathway","volume":"286","author":"Tacke","year":"2011","journal-title":"J Biol Chem"},{"key":"R23-5-20240828","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/hep.510300429","article-title":"Hepatitis C virus core protein binds to apolipoprotein AII and its secretion is modulated by fibrates","volume":"30","author":"Sabile","year":"1999","journal-title":"Hepatology"},{"key":"R24-5-20240828","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/intimm\/dxr104","article-title":"HCV core and NS3 proteins manipulate human blood-derived dendritic cell development and promote Th 17 differentiation","volume":"24","author":"Tu","year":"2012","journal-title":"Int Immunol"},{"key":"R25-5-20240828","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/hep.22849","article-title":"Hepatitis C virus core protein triggers hepatic angiogenesis by a mechanism including multiple pathways","volume":"49","author":"Hassan","year":"2009","journal-title":"Hepatology"},{"key":"R26-5-20240828","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1053\/jhep.2001.20794","article-title":"Hepatitis C virus core protein enhances the activation of the transcription factor, Elk1, in response to mitogenic stimuli","volume":"33","author":"Fukuda","year":"2001","journal-title":"Hepatology"},{"key":"R27-5-20240828","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3748\/wjg.v25.i1.42","article-title":"Hepatitis C virus core protein modulates several signaling pathways involved in hepatocellular carcinoma","volume":"25","author":"Mahmoudvand","year":"2019","journal-title":"World J Gastroenterol"},{"key":"R28-5-20240828","doi-asserted-by":"crossref","first-page":"14234","DOI":"10.1038\/s41598-018-32464-5","article-title":"Transcriptional regulatory networks in hepatitis C virus-induced hepatocellular carcinoma","volume":"8","author":"Zahra","year":"2018","journal-title":"Sci Rep"},{"key":"R29-5-20240828","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1128\/JVI.76.18.9345-9354.2002","article-title":"Hepatitis C virus core protein leads to immune suppression and liver damage in a transgenic murine model","volume":"76","author":"Soguero","year":"2002","journal-title":"J Virol"},{"key":"R30-5-20240828","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1042\/bst0280051","article-title":"Role of the BH3 (Bcl-2 homology 3) domain in the regulation of apoptosis and Bcl-2-related proteins","volume":"28","author":"Lutz","year":"2000","journal-title":"Biochem Soc Trans"},{"key":"R31-5-20240828","doi-asserted-by":"crossref","first-page":"9993","DOI":"10.1128\/JVI.00509-09","article-title":"The hepatitis C virus core protein contains a BH3 domain that regulates apoptosis through specific interaction with human Mcl-1","volume":"83","author":"Mohd-Ismail","year":"2009","journal-title":"J Virol"},{"key":"R32-5-20240828","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1038\/sj.onc.1208673","article-title":"Hepatitis C virus core triggers apoptosis in liver cells by inducing ER stress and ER calcium depletion","volume":"24","author":"Benali-Furet","year":"2005","journal-title":"Oncogene"},{"key":"R33-5-20240828","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1128\/JVI.73.6.4713-4720.1999","article-title":"Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation","volume":"73","author":"Marusawa","year":"1999","journal-title":"J Virol"},{"key":"R34-5-20240828","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1128\/JVI.80.9.4372-4379.2006","article-title":"Hepatitis C virus core protein inhibits tumor necrosis factor alpha-mediated apoptosis by a protective effect involving cellular FLICE inhibitory protein","volume":"80","author":"Saito","year":"2006","journal-title":"J Virol"},{"key":"R35-5-20240828","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00535-005-1738-1","article-title":"Hepatitis C virus core protein inhibits deoxycholic acid-mediated apoptosis despite generating mitochondrial reactive oxygen species","volume":"41","author":"Hara","year":"2006","journal-title":"J Gastroenterol"},{"key":"R36-5-20240828","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1186\/1743-422X-8-522","article-title":"Anti-apoptotic effect of HCV core gene of genotype 3a in Huh-7 cell line","volume":"8","author":"Jahan","year":"2011","journal-title":"Virol J"},{"key":"R37-5-20240828","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1006\/viro.2000.0295","article-title":"Hepatitis C virus core protein promotes immortalization of primary human hepatocytes","volume":"271","author":"Ray","year":"2000","journal-title":"Virology"},{"key":"R38-5-20240828","doi-asserted-by":"crossref","first-page":"7648","DOI":"10.1128\/JVI.79.12.7648-7657.2005","article-title":"Hepatitis C virus core protein suppresses NF-kappaB activation and cyclooxygenase-2 expression by direct interaction with IkappaB kinase beta","volume":"79","author":"Joo","year":"2005","journal-title":"J Virol"},{"key":"R39-5-20240828","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/jmv.20283","article-title":"Hepatitis C virus core, NS3, NS5A, NS5B proteins induce apoptosis in mature dendritic cells","volume":"75","author":"Siavoshian","year":"2005","journal-title":"J Med Virol"},{"key":"R40-5-20240828","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jhep.2008.12.026","article-title":"Hepatitis C virus NS5A and core proteins induce oxidative stress-mediated calcium signalling alterations in hepatocytes","volume":"50","author":"Dionisio","year":"2009","journal-title":"J Hepatol"},{"key":"R41-5-20240828","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.virol.2006.02.023","article-title":"Microarray analyses and molecular profiling of Stat3 signaling pathway induced by hepatitis C virus core protein in human hepatocytes","volume":"349","author":"Basu","year":"2006","journal-title":"Virology"},{"key":"R42-5-20240828","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3389\/fcimb.2020.00135","article-title":"Marmoset viral hepatic inflammation induced by hepatitis C virus core protein via IL-32","volume":"10","author":"Liu","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"R43-5-20240828","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1006\/viro.2000.0694","article-title":"Hepatitis C virus core protein inhibits interleukin 12 and nitric oxide production from activated macrophages","volume":"279","author":"Lee","year":"2001","journal-title":"Virology"},{"key":"R44-5-20240828","doi-asserted-by":"crossref","first-page":"43479","DOI":"10.1074\/jbc.M407640200","article-title":"Hepatitis C virus core selectively suppresses interleukin-12 synthesis in human macrophages by interfering with AP-1 activation","volume":"279","author":"Eisen-Vandervelde","year":"2004","journal-title":"J Biol Chem"},{"key":"R45-5-20240828","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.intimp.2016.06.013","article-title":"IL-10 plays a central regulatory role in the cytokines induced by hepatitis C virus core protein and polyinosinic acid: Polycytodylic acid","volume":"38","author":"Pang","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"R46-5-20240828","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1086\/429301","article-title":"Effect of heptitis C virus core protein on cellular gene expression: Specific inhibition of cyclooxygenase 2","volume":"191","author":"Jhaveri","year":"2005","journal-title":"J Infect Dis"},{"key":"R47-5-20240828","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3389\/fimmu.2014.00461","article-title":"Toll-like receptor signaling pathways","volume":"5","author":"Kawasaki","year":"2014","journal-title":"Front Immunol"},{"key":"R48-5-20240828","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1159\/000226136","article-title":"Toll-like receptor 2 senses hepatitis C virus core protein but not infectious viral particles","volume":"1","author":"Hoffmann","year":"2009","journal-title":"J Innate Immun"},{"key":"R49-5-20240828","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1743-422X-9-126","article-title":"Interaction of hepatitis C virus proteins with pattern recognition receptors","volume":"9","author":"Imran","year":"2012","journal-title":"Virol J"},{"key":"R50-5-20240828","first-page":"1388","article-title":"Hepatitis C virus core and NS3 antigens induced conjunctival inflammation via toll-like receptor-mediated signaling","volume":"20","author":"Rajalakshmy","year":"2014","journal-title":"Mol Vis"},{"key":"R51-5-20240828","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1053\/j.gastro.2004.08.067","article-title":"Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation","volume":"127","author":"Dolganiuc","year":"2004","journal-title":"Gastroenterology"},{"key":"R52-5-20240828","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1189\/jlb.0207128","article-title":"Toll-like receptors 1 and 6 are involved in TLR2-mediated macrophage activation by hepatitis C virus core and NS3 proteins","volume":"82","author":"Chang","year":"2007","journal-title":"J Leukoc Biol"},{"key":"R53-5-20240828","first-page":"7315","article-title":"Toll-like receptor 2 promotes T helper 17 cells response in hepatitis B virus infection","volume":"8","author":"Zhao","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"R54-5-20240828","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1086\/655812","article-title":"Hepatitis C virus core protein induces homotolerance and cross-tolerance to Toll-like receptor ligands by activation of Toll-like receptor 2","volume":"202","author":"Chung","year":"2010","journal-title":"J Infect Dis"},{"key":"R55-5-20240828","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1084\/jem.20121517","article-title":"Revealing the role of CD4(+) T cells in viral immunity","volume":"209","author":"Sant","year":"2012","journal-title":"J Exp Med"},{"key":"R56-5-20240828","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1084\/jem.188.2.223","article-title":"Contribution of virus-specific CD8+cytotoxic T cells to virus clearance or pathologic manifestations of influenza virus infection in a T cell receptor transgenic mouse model","volume":"188","author":"Moskophidis","year":"1998","journal-title":"J Exp Med"},{"key":"R57-5-20240828","doi-asserted-by":"crossref","first-page":"36160","DOI":"10.1038\/srep36160","article-title":"HCV core protein inhibits polarization and activity of both M1 and M2 macrophages through the TLR2 signaling pathway","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci Rep"},{"key":"R58-5-20240828","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1189\/jlb.0507268","article-title":"HCV core protein interaction with gC1q receptor inhibits Th1 differentiation of CD4+T cells via suppression of dendritic cell IL-12 production","volume":"82","author":"Waggoner","year":"2007","journal-title":"J Leukoc Biol"},{"key":"R59-5-20240828","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/imm.12882","article-title":"Hepatitis C virus core protein reduces CD8+T-cell proliferation, perforin production and degranulation but increases STAT5 activation","volume":"154","author":"Khan","year":"2018","journal-title":"Immunology"},{"key":"R60-5-20240828","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2119\/2006-00020.Wu","article-title":"Effect of hepatitis C virus core protein on the molecular profiling of human B lymphocytes","volume":"12","author":"Wu","year":"2006","journal-title":"Mol Med"},{"key":"R61-5-20240828","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.jhep.2019.06.031","article-title":"Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease","volume":"71","author":"Rosso","year":"2019","journal-title":"J Hepatol"},{"key":"R62-5-20240828","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1172\/JCI96139","article-title":"Insulin resistance causes inflammation in adipose tissue","volume":"128","author":"Shimobayashi","year":"2018","journal-title":"J Clin Invest"},{"key":"R63-5-20240828","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev-physiol-021909-135846","article-title":"Macrophages, inflammation, and insulin resistance","volume":"72","author":"Olefsky","year":"2010","journal-title":"Annu Rev Physiol"},{"key":"R64-5-20240828","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-2893.2011.01447.x","article-title":"Hepatitis C core protein impairs insulin downstream signalling and regulatory role of IGFBP-1 expression","volume":"19","author":"Alberstein","year":"2012","journal-title":"J Viral Hepat"},{"key":"R65-5-20240828","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1080\/00365521.2017.1379556","article-title":"IGFBP-1 and IGF-I as markers for advanced fibrosis in NAFLD-A pilot study","volume":"52","author":"Hagstr\u00f6m","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"R66-5-20240828","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1089-3261(02)00065-X","article-title":"Hepatitis C virus genetic variability: Pathogenic and clinical implications","volume":"7","author":"Pawlotsky","year":"2003","journal-title":"Clin Liver Dis"},{"key":"R67-5-20240828","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.26744","article-title":"Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource","volume":"59","author":"Smith","year":"2014","journal-title":"Hepatology"},{"key":"R68-5-20240828","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1128\/JCM.02831-14","article-title":"Hepatitis C virus genotype 7, a new genotype originating from central Africa","volume":"53","author":"Murphy","year":"2015","journal-title":"J Clin Microbiol"},{"key":"R69-5-20240828","doi-asserted-by":"crossref","first-page":"548280","DOI":"10.1155\/2010\/548280","article-title":"A new insight into hepatitis C vaccine development","volume":"2010","author":"Yu","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"R70-5-20240828","first-page":"309","article-title":"The genotype of hepatitis C virus has important clinical and therapeutic implications","volume":"20","author":"Hsieh","year":"2009","journal-title":"J Intern Med Taiwan"},{"key":"R71-5-20240828","doi-asserted-by":"crossref","first-page":"e0205186","DOI":"10.1371\/journal.pone.0205186","article-title":"Hepatitis C virus genetic diversity by geographic region within genotype 1-6 subtypes among patients treated with glecaprevir and pibrentasvir","volume":"13","author":"Schnell","year":"2018","journal-title":"PLoS One"},{"key":"R72-5-20240828","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1158\/1078-0432.CCR-08-2418","article-title":"Mutations in the hepatitis C virus core gene are associated with advanced liver disease and hepatocellular carcinoma","volume":"15","author":"Fishman","year":"2009","journal-title":"Clin Cancer Res"},{"key":"R73-5-20240828","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000505434","article-title":"Evolution and revolution of hepatitis C management: From non-A, non-B hepatitis toward global elimination","volume":"38","author":"Basyte-Bacevice","year":"2020","journal-title":"Dig Dis"},{"key":"R74-5-20240828","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature04082","article-title":"Mechanism of action of interferon and ribavirin in treatment of hepatitis C","volume":"436","author":"Feld","year":"2005","journal-title":"Nature"},{"key":"R75-5-20240828","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/S0016-5085(03)00290-7","article-title":"Expression of hepatitis c virus proteins inhibits interferon alpha signaling in the liver of transgenic mice","volume":"124","author":"Blindenbacher","year":"2003","journal-title":"Gastroenterology"},{"key":"R76-5-20240828","first-page":"1000","article-title":"Study of the effect of hepatitis C virus core protein on interferon-induced antiviral genes expression and its mechanisms","volume":"23","author":"Chang","year":"2007","journal-title":"Sheng Wu Gong Cheng Xue Bao"},{"key":"R77-5-20240828","doi-asserted-by":"crossref","first-page":"9226","DOI":"10.1128\/JVI.00459-06","article-title":"Hepatitis C virus core protein blocks interferon signaling by interaction with the STAT1 SH2 domain","volume":"80","author":"Lin","year":"2006","journal-title":"J Virol"},{"key":"R78-5-20240828","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.meegid.2011.01.017","article-title":"Sequence variability of HCV Core region: Important predictors of HCV induced pathogenesis and viral production","volume":"11","author":"Khaliq","year":"2011","journal-title":"Infect Genet Evol"},{"key":"R79-5-20240828","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jmv.20507","article-title":"Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load","volume":"78","author":"Akuta","year":"2006","journal-title":"J Med Virol"},{"key":"R80-5-20240828","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.jhep.2017.01.028","article-title":"Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort","volume":"66","author":"Calleja","year":"2017","journal-title":"J Hepatol"},{"key":"R81-5-20240828","doi-asserted-by":"crossref","first-page":"ofy001","DOI":"10.1093\/ofid\/ofy001","article-title":"Sofosbuvir-based direct-acting antiviral therapies for HCV in people receiving opioid substitution therapy: An analysis of phase 3 studies","volume":"5","author":"Grebely","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"R82-5-20240828","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1111\/jgh.14615","article-title":"Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection","volume":"34","author":"Liu","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"R83-5-20240828","doi-asserted-by":"crossref","first-page":"100268","DOI":"10.1016\/j.aohep.2020.09.012","article-title":"Real-world effectiveness of direct-acting antiviral regimens against hepatitis C virus (HCV) genotype 3 infection: A systematic review and meta-analysis","volume":"23","author":"Zhuang","year":"2020","journal-title":"Ann Hepatol"},{"key":"R84-5-20240828","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of PPAR\u03b1 action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"Pawlak","year":"2015","journal-title":"J Hepatol"},{"key":"R85-5-20240828","doi-asserted-by":"crossref","first-page":"10596","DOI":"10.1038\/s41598-019-46664-0","article-title":"Virus genotype-dependent transcriptional alterations in lipid metabolism and inflammation pathways in the hepatitis C virus-infected liver","volume":"9","author":"d'Avigdor","year":"2019","journal-title":"Sci Rep"},{"key":"R86-5-20240828","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tem.2009.07.005","article-title":"Hepatitis C virus hijacks host lipid metabolism","volume":"21","author":"Syed","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"R87-5-20240828","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/hep.22288","article-title":"Morphological changes in intracellular lipid droplets induced by different hepatitis C virus genotype core sequences and relationship with steatosis","volume":"48","author":"Piodi","year":"2008","journal-title":"Hepatology"},{"key":"R88-5-20240828","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jhep.2004.12.034","article-title":"An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation","volume":"42","author":"Abid","year":"2005","journal-title":"J Hepatol"},{"key":"R89-5-20240828","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12929-020-00669-4","article-title":"Hepatitis C virus vaccine design: Focus on the humoral immune response","volume":"27","author":"Sepulveda-Crespo","year":"2020","journal-title":"J Biomed Sci"},{"key":"R90-5-20240828","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1126\/science.aad1302","article-title":"MEDICINE.Global control of hepatitis C virus","volume":"349","author":"Cox","year":"2015","journal-title":"Science"},{"key":"R91-5-20240828","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(19)32320-7","article-title":"Hepatitis C","volume":"394","author":"Spearman","year":"2019","journal-title":"Lancet"},{"key":"R92-5-20240828","first-page":"207","article-title":"Hepatitis C virus and vaccine development","volume":"3","author":"Naderi","year":"2014","journal-title":"Int J Mol Cell Med"},{"key":"R93-5-20240828","doi-asserted-by":"crossref","first-page":"8239","DOI":"10.1073\/pnas.91.17.8239","article-title":"Sequence analysis of the core gene of 14 hepatitis C virus genotypes","volume":"91","author":"Bukh","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R94-5-20240828","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.3390\/v2081734","article-title":"Core as a novel viral target for hepatitis C drugs","volume":"2","author":"Strosberg","year":"2010","journal-title":"Viruses"},{"key":"R95-5-20240828","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/j.bmcl.2011.03.014","article-title":"Potent inhibitors of hepatitis C core dimerization as new leads for anti-hepatitis C agents","volume":"21","author":"Ni","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"R96-5-20240828","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1128\/JVI.03312-13","article-title":"Inhibition of hepatitis C virus production by aptamers against the core protein","volume":"88","author":"Shi","year":"2014","journal-title":"J Virol"},{"key":"R97-5-20240828","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/gut.2005.069757","article-title":"Steatosis in chronic hepatitis C: Why does it really matter?","volume":"55","author":"Asselah","year":"2006","journal-title":"Gut"},{"key":"R98-5-20240828","first-page":"24","article-title":"Steatosis and hepatitis C","volume":"4","author":"Modaresi Esfeh","year":"2016","journal-title":"Gastroenterol Rep (Oxf"}],"container-title":["Tzu Chi Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/tcmj.tcmj_97_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:05:36Z","timestamp":1787166336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/tcmj.tcmj_97_21"}},"subtitle":["Not just a nucleocapsid building block, but an immunity and inflammation modulator"],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":97,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/tcmj.tcmj_97_21","relation":{},"ISSN":["1016-3190"],"issn-type":[{"value":"1016-3190","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]}}}